Resident Research Presentations

The following presentations will be given by our residents at the 2016 American Society for Radiation Oncology (ASTRO) annual meeting. Many of our residents have received grants and awards for their work.

Research Presentations

Initial report on safety and lesion response of melanoma brain metastases after stereotactic radiosurgery or hypofractionated radiation therapy in patients receiving concurrent pembrolizumab
Erik Anderson

Overall Survival of Breast Cancer Patients with Recurrent Disease Involving Internal Mammary Nodes
Amy Xu

Outcomes for locally advanced laryngeal cancer treated with definitive chemo-radiation with IMRT
Robert Samstein

Planning target volume and FDG-PET maximum standardized uptake value, but not dosimetric parameters of target coverage, predict for local recurrence after stereotactic body radiation therapy for non-small cell lung cancer
Aaron Wild

PIK3CA activating mutations are associated with decreased local control in lung cancer brain metastases treated with radiation
Natalie Lockney

Patterns of nodal failure after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma
Quincey LaPlant

Histologic Subtype of Early Stage Lung Adenocarcinoma Predicts Failure Patterns in Patients Treated with SBRT
Jonathan Leeman

Comparison of Outcomes Following Recurrence or Metastasis in HPV+ and HPV- Oropharyngeal Carcinoma Treated with Definitive Chemoradiation Using IMRT
Jonathan Leeman

Natural History Following Recurrence After Definitive Locoregional Treatment in 1000+ Cases of Locally Advanced Head and Neck Squamous Cell Carcinoma
Jonathan Leeman

Patterns of Regional Nodal Failure Following Intensity Modulated Radiotherapy for Head and Neck Squamous Cell Carcinoma
Jonathan Leeman

Brentuximab vedotin and AVD chemotherapy followed by ISRT: a safe primary treatment regimen for early stage, unfavorable Hodgkin lymphoma
Joanna Yang

Langerhans Cell Histiocytosis (LCH) in the Modern Era:  Excellent Local Control with Radiotherapy (RT)
Benjamin Lok

Irradiation for Regionally Only Recurrent, Never-Irradiated Oral Cavity Cancers 
Benjamin Lok

SLFN11 is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, but not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell  Lines and Patient-Derived Xenografts (PDX) 
Benjamin Lok

Monitoring Prostate Cancer Treatment Response to Radiation Therapy and Androgen Deprivation with Novel Radiolabeled and Dual-Labeled Gastrin-Releasing Peptide Receptor (GRPr) Antagonists
Neil Taunk

The Relationship of Numerical Chromosomal Instability with Clinical Characteristics and Outcomes in Head and Neck Cancers Treated with Multimodality Therapy
Neil Taunk

Localized prostate cancers with genetic defects in DNA repair display evidence of functional deficit in homologous recombination
Jeremy Setton

Radiation Sensitizes Tumor Cells to CAR T Cell Immunotherapy
Carl Deselm

Regional Patterns of Breast Cancer Failure after Definitive Therapy: A Large, Single-Institution Analysis
Carl Deselm

Cost-effectiveness analysis of early salvage radiation therapy versus adjuvant radiation therapy after radical prostatectomy
Leo Luo

Research Awards and Grants

Samuel Bakhoum
Department of Defense (DoD) Breast Cancer Breakthrough Award, 3 year-grant, 2016-2019
Elsa U. Pardee Foundation Grant, 2016-2017

Jonathan Leeman
American Society of Clinical Oncology (ASCO) Conquer Cancer Merit Award, 2016

Natalie Lockney
American College of Radiation Oncology (ACRO) Resident Seed Grant, 2015

Benjamin Lok
Lung Cancer Research Foundation (LCRF) Grant, 2 year-grant, 2016-2018​​​​​​​
American Association for Cancer Research (AACR) Takeda Scholar-in-Training Award, 2016
Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Young Investigator Award, 2016
Radiological Society of North America (RSNA) Resident Research Grant, 2016

Neil Taunk
IMRAS (Imaging and Radiation Sciences) Seed Grant, 2016